Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Biological & Pharmaceutical Bulletin
|
November 14, 1997
The novel compound NO-1886 activates lipoprotein lipase in primary cultured adipose and skeletal muscle cells
A Hagi, I Hirai, H Kohri, et al.
Biological & Pharmaceutical Bulletin
|
August 14, 1998
Streptozotocin-induced diabetic cynomolgus monkey is a model of hypertriglyceridemia with low high-density lipoprotein cholesterol
K Tsutsumi, T Iwamoto, A Hagi, et al.
Coronary Artery Disease
|
October 1, 1995
Effects of OG-VI, a nucleoside/nucleotide mixture, and its constituents on myocardial stunning in dogs
S Kano, T Nakai, H Kohri, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
April 1, 1976
[Metabolic fate of carteolol hydrochloride (OPC-1085), a new beta-adrenergic agent. (3) Autoradiographic total body distribution studies in mice]
H Kohri, S Morita, K Nakagawa, et al.
Arzneimittel-Forschung
|
January 1, 1979
Metabolic fate of a new beta2-adrenergic stimulant procaterol (OPC-2009). Absorption, distribution, metabolism and excretion in the beagle dog
Y Yasuda, N Fujisawa, S Morita, et al.
Biochemical Pharmacology
|
August 15, 1976
Evaluation of a new beta-adrenergic blocking agent, carteolol, based on metabolic responses in rats-II. Blockade by carteolol of the epinephrine-and isoproterenol-induced increases of tissue and blood cyclic AMP in vivo
Y Saitoh, S Morita, Y Irie, et al.
Biological & Pharmaceutical Bulletin
|
May 24, 2000
Amitriptyline-induced constipation in cynomolgus monkeys is beneficial for the evaluation of laxative efficacy
K Tsusumi, S Kishimoto, O Koshitani, et al.
Biochemical Pharmacology
|
August 15, 1976
Evaluation of a new beta-adrenergic blocking agent, carteolol, based on metabolic responses in rats-I. Blockade in vivo of epinephrine- and isoproterenol-induced alterations of blood concentrations of carbohydrate and lipid intermediary metabolites
S Morita, Y Irie, Y Saitoh, et al.
Journal of Nutritional Science and Vitaminology
|
October 1, 1992
Determination of absorption and endogenous excretion of iron in man by monitoring fecal excretion of a stable iron isotope (58Fe)
F Hashimoto, Y Fujii, M Toba, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
January 1, 1977
[Fluorometric determination of 5-(3-tert-butylamino-2hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride (OPC-1085) and structure of fluorescent substance (author's transl)]
M Kido, H Mori, S Masuda, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Biological & Pharmaceutical Bulletin
|
November 14, 1997
The novel compound NO-1886 activates lipoprotein lipase in primary cultured adipose and skeletal muscle cells
A Hagi, I Hirai, H Kohri, et al.
Biological & Pharmaceutical Bulletin
|
August 14, 1998
Streptozotocin-induced diabetic cynomolgus monkey is a model of hypertriglyceridemia with low high-density lipoprotein cholesterol
K Tsutsumi, T Iwamoto, A Hagi, et al.
Coronary Artery Disease
|
October 1, 1995
Effects of OG-VI, a nucleoside/nucleotide mixture, and its constituents on myocardial stunning in dogs
S Kano, T Nakai, H Kohri, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
April 1, 1976
[Metabolic fate of carteolol hydrochloride (OPC-1085), a new beta-adrenergic agent. (3) Autoradiographic total body distribution studies in mice]
H Kohri, S Morita, K Nakagawa, et al.
Arzneimittel-Forschung
|
January 1, 1979
Metabolic fate of a new beta2-adrenergic stimulant procaterol (OPC-2009). Absorption, distribution, metabolism and excretion in the beagle dog
Y Yasuda, N Fujisawa, S Morita, et al.
Biochemical Pharmacology
|
August 15, 1976
Evaluation of a new beta-adrenergic blocking agent, carteolol, based on metabolic responses in rats-II. Blockade by carteolol of the epinephrine-and isoproterenol-induced increases of tissue and blood cyclic AMP in vivo
Y Saitoh, S Morita, Y Irie, et al.
Biological & Pharmaceutical Bulletin
|
May 24, 2000
Amitriptyline-induced constipation in cynomolgus monkeys is beneficial for the evaluation of laxative efficacy
K Tsusumi, S Kishimoto, O Koshitani, et al.
Biochemical Pharmacology
|
August 15, 1976
Evaluation of a new beta-adrenergic blocking agent, carteolol, based on metabolic responses in rats-I. Blockade in vivo of epinephrine- and isoproterenol-induced alterations of blood concentrations of carbohydrate and lipid intermediary metabolites
S Morita, Y Irie, Y Saitoh, et al.
Journal of Nutritional Science and Vitaminology
|
October 1, 1992
Determination of absorption and endogenous excretion of iron in man by monitoring fecal excretion of a stable iron isotope (58Fe)
F Hashimoto, Y Fujii, M Toba, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
January 1, 1977
[Fluorometric determination of 5-(3-tert-butylamino-2hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride (OPC-1085) and structure of fluorescent substance (author's transl)]
M Kido, H Mori, S Masuda, et al.
Page
of 5